Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
140.73%EBITDA Margin
VS
Market
Sector
Industry
History
$ 1.65Close
$ 0.67 - $ 1.82 52-Week Range
Ticker Information
Ticker
CHRSCompany Name
COHERUS ONCOLOGY INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQCOHERUS ONCOLOGY INC - EBITDA Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
CHRS - EBITDA % Historical data
| Date | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 200.92M | 140.73% | $ 142.77M |
| 3/31/2025 | $ -106.54M | -53.94% | $ 197.5M |
| 12/31/2024 | $ 62.34M | 23.35% | $ 266.96M |
| 9/30/2024 | $ 37.75M | 12.4% | $ 304.34M |
| 6/30/2024 | $ 13.47M | 4.37% | $ 308.13M |
| 3/31/2024 | $ -10.9M | -3.61% | $ 301.87M |
| 12/31/2023 | $ -191.46M | -74.43% | $ 257.24M |
| 9/30/2023 | $ -172.39M | -81.67% | $ 211.07M |
| 6/30/2023 | $ -222.39M | -122.24% | $ 181.93M |
| 3/31/2023 | $ -234.3M | -127.78% | $ 183.36M |
Key Performance Insights, Last 5 Years
- COHERUS ONCOLOGY INC's latest trailing twelve months (TTM) EBITDA % stands at 39.11%.
- Over the past 5 years, COHERUS ONCOLOGY INC's average EBITDA % has been -37.21%.
- The median EBITDA % for COHERUS ONCOLOGY INC during this period was -54.78%
- COHERUS ONCOLOGY INC reached its highest EBITDA % over the past 5 years at 140.73%.
- The lowest EBITDA % recorded by COHERUS ONCOLOGY INC in the same timeframe -127.78%
COHERUS ONCOLOGY INC's EBITDA % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDA % Benchmarks
Similar metrics to Revenues:
- EBIT Margin - [Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Free Cash Flow Margin - [Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.
- Enterprise Value over EBITDA - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
Definition of EBITDA Margin
[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.EBITDA / Revenues
(=) EBITDA % EBITDA % for COHERUS ONCOLOGY INC is calculated as follows: EBITDA [ $ 191.35M ] / Revenues [ $ 489.26M ]
(=) EBITDA % [ 39.11% ] CHRS - EBITDA Margin, Last 5 years
-127.78%
Minimum
Mar 31, 2023
140.73%
Maximum
Jun 30, 2025
-37.21%
Average
-54.78%
Median
EBITDA % Benchmark AnalysisMarket
The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.12% with a standard deviation of 26.88%.
The following table provides additional summary stats:
EBITDA % in the Market:
| filtered constituents | 3.29K |
|---|---|
| min | -75.07% |
| max | 97.73% |
| average | 16.12% |
| median | 14.72% |
| std | 26.88% |